Targeted delivery of the PKMYT1 inhibitor RP-6306 mediates PANoptosis in pancreatic cancer via mitotic catastrophe
Abstract Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant tumor often diagnosed in advanced stages due to its subtle early symptoms, making surgical options nonviable and requiring systemic chemotherapy. Current treatments mainly utilize gemcitabine, which provides limited efficacy. PKM...
Saved in:
| Main Authors: | Jingyun Chen, Jianghao Ren, Chaolei Zhang, Yang Lv, Jingbin Zhou, Weiliang Jiang, Chaojie Huang, Liping Cao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-07-01
|
| Series: | Cell Death and Disease |
| Online Access: | https://doi.org/10.1038/s41419-025-07835-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Discovery of CMNPD31124 as a novel marine-derived PKMYT1 inhibitor for pancreatic ductal adenocarcinoma therapy: computational and biological insights
by: Chaojie Huang, et al.
Published: (2025-04-01) -
Structure-based discovery and experimental validation of HIT101481851 as a potential PKMYT1 inhibitor for pancreatic cancer
by: Ting Wang, et al.
Published: (2025-06-01) -
PKMYT1 kinase ameliorates cisplatin sensitivity in osteosarcoma
by: Binfeng Liu, et al.
Published: (2025-05-01) -
Unleashing the Power of Cold Atmospheric Plasma: Inducing Mitochondria Damage‐Mediated Mitotic Catastrophe
by: Shengjie Peng, et al.
Published: (2024-12-01) -
Diagnostic value of the correlation between urinary MDM2 and podocyte mitotic catastrophe in diabetic kidney disease
by: Li Xu, et al.
Published: (2025-07-01)